4 trends tracked about this subject — the full history, oldest to newest below.
The European Medicines Agency has issued a positive opinion recommending the approval of Eli Lilly's Jaypirca for chronic lymphocytic leukemia.
Developments in oral GLP-1 therapy are shifting the focus of obesity management from injectables to daily pill formats.
8 news sources are covering this Business story right now — PULSE is tracking how fast it spreads.
Eli Lilly reports positive initial Phase 1 clinical data for its $2.3 billion acquisition of Ajax Therapeutics' myelofibrosis treatment.